COMPANY

Seraxis

HQ: Germantown, MD source · seraxis.com ↗

Keywords: cell therapy metabolic diabetes mellitus Diabete Mellitus Diabete Type 1 Diabetes Mellitus Type 1 Allogeneic pancreatic endocrine cell clusters

Location: Germantown, MD · source · Oct 14, 2026

Profile checked Oct 10, 2026

2Trials (company is sponsor)

Timeline

2026-11 Trial start Phase 1/Phase 2: Study of the Safety and Efficacy of Pancreatic Endocrine Cells in Adult Patients With Type 1 Diabetes source ↗
2025-04 Trial start Phase 1/Phase 2: A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia source ↗

Upcoming milestones

2028-11 (ESTIMATED) · Phase 1/Phase 2 · Study of the Safety and Efficacy of Pancreatic Endocrine Cells in Adult Patients With Type 1 Diabetes · NCT07581197

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT07581197	Study of the Safety and Efficacy of Pancreatic Endocrine Cells in Adult Patients With Type 1 Diabetes	Phase 1/Phase 2	Not yet recruiting	2026-11	2028-11 (estimated)
NCT06651515	A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia	Phase 1/Phase 2	Withdrawn	2025-04	2027-03 (estimated)